AI Roundtable

The T2B AI Roundtable connects biopharma communicators exploring the role of artificial intelligence in their work, focusing on real-world applications in our highly regulated industry. This roundtable offers a collaborative space to exchange ideas, tackle challenges, and uncover ways AI can amplify the strategic impact of communication professionals within their organizations and for their clients.

Roundtable objectives

  • Build confidence in understanding and using AI tools by tailoring conversations to the unique needs of biopharma communicators.
  • Share practical examples of AI-driven solutions for content creation, data analysis, and workflow optimization, all while maintaining creativity and integrity.
  • Address ethical considerations and build understanding around human oversight, ensuring AI enhances storytelling without compromising trust, privacy, or empathy.
  • Cultivate forward-looking perspectives on AI’s value and role in the profession, helping communicators lead innovation and anticipate future trends within their organizations and the broader industry.

Upcoming & Recent AI Roundtables

Upcoming

More details on our next Roundtable coming soon!

Chair
Delphine Caraguel

Delphine Caraguel

Global VP, Head of Marketing & Communications

Minaris Advanced Therapies

Roundtable members

Monica Aguilar

Monica Aguilar

Chief AI Officer

Dragonfly Consulting

Ryan Flinn

Ryan Flinn

Writer/Communicator

In Like Flinn Communications

Nathaniel Reagan

Nathaniel Reagan

AI Educator & Comms Strategist

AI Learning Labs

Matthew Snodgrass

Matthew Snodgrass

AI Innovation Lead

Syneos Health

Cameron Stow

Cameron Stow

Social Media Manager

Perplexity

Chief of Staff / PM
Jennifer Smith-Parker

Jennifer Smith-Parker

Director of Insights

BioSpace

“I’m excited to connect with AI enthusiasts and explore how generative AI can transform communications and content-driven roles. Gen AI is only starting to impact the world, and while many of us are just beginning this journey, sharing experiences will accelerate our AI literacy and help us apply it effectively to benefit our teams and careers.”

Delphine Caraguel

Global VP, Head of Marketing & Communications, Minaris Advanced Therapies

Interested in joining this roundtable?

Why join

  • Explore the rapidly evolving landscape of AI in life sciences marketing and communications, and share hands-on insights with peers navigating similar challenges and opportunities.
  • Help shape responsible, effective, and forward-thinking applications of AI that drive mar-comm innovation—from campaign personalization to predictive analytics.
  • Collaborate with a dynamic network of biopharma mar-comm leaders to elevate your strategic thinking and grow your visibility within the T2B community of 1K+ professionals.

Eligibility requirements

Applicants must have:

  • A strong interest and some hands on experience in the intersection of AI and communications / marketing within the life sciences sector.
  • The ability to contribute 3–5 hours/month to help design quarterly roundtable events and ongoing content/resources for the broader T2B community.
  • A willingness to participate in quarterly planning meetings and to collaborate actively with fellow roundtable volunteers.
  • An active T2B Pro membership.

Apply for a spot on the AI Roundtable

Applications are closed and will reopen in August 2026. Each member term is for one calendar year.